RONALD OGLESBY: Open Payments
NPI 1578595955 · BROKEN ARROW, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,609 in 86 payments from 19 companies in 2025. Trend: 2023 $2,415 · 2024 $1,818 · 2025 $1,609
Food & beverage: $1,609
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $220 |
| PFIZER INC. | 15 | $218 |
| Novo Nordisk Inc | 13 | $192 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $183 |
| AstraZeneca Pharmaceuticals LP | 4 | $164 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $157 |
| GlaxoSmithKline, LLC. | 6 | $102 |
| Lilly USA, LLC | 3 | $59 |
| ABBVIE INC. | 3 | $52 |
| Inspire Medical Systems, Inc. | 2 | $49 |
Products named: FREESTYLE LIBRE 3, Kerendia, CAPLYTA, AIRSUPRA, ELIQUIS, PREVNAR 20, Ozempic, TRELEGY ELLIPTA.
Industry payments across OK — which companies pay providers there.
